PANAGIOTIS PLOTAS

ASSISTANT PROFESSOR, GENERAL PRACTICE

Phone : (+30) 2610 962813
Email : pplotas@upatras.gr

 

 

ACADEMIC TITLES

  • Specialty in General Practice in Rion University Hospital, Patras, Greece (2017)
  • Doctor of Philosophy, School of Medicine, University of Patras (2014)
  • Master of Sciences, Graduate Program “Medicinal Chemistry” , Departments Chemistry and Pharmacy, University of Patras (2011)
  • Graduated from the Medical School, University of Patras, Greece (2008)

PROFESSIONAL EXPERIENCE

  • Consultant, Ano Hora Health Center, in region Aitoloakarnania(2020-2021)
  • Consultant, Ano Poli Patras Health Center, in region Achaia (2018-2019)
  • Academic Scholar in Primary Health Care, Department of Pharmacy, University of Patras (2018)
  • Academic Scholar in Phmaceutical Care & Health Education, Department of Pharmacy, University of Patras(2018)

RESEARCH INTERESTS

  • Preventive Medicine
  • Primary Health Care
  • Health promotion
  • Health education
  • General Practice
  • Clinical Medicine

TEACHING

Undergraduate Course

  • SLT_103 Anatomy-Physiology of Hearing, Speech, Speech
  • SLT_201 Medical Sciences in Speech and Language Therapy I
  • SLT_301 Medical Sciences in Speech and Language Therapy II
  • SLT_803 Academic Writing

Postgraduate Course

(Master in HEALTH EDUCATION)

  • HE_102 Academic Writing I
  • HE_104 Family Medicine and Primary Health Care

SELECTED PUBLICATIONS

  • Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity. Ridgway H, Ntallis C, Chasapis CT, Kelaidonis K, Matsoukas MT, Plotas P, Apostolopoulos V, Moore G, Tsiodras S, Paraskevis D, Mavromoustakos T, Matsoukas JM. Viruses. 2023 Jan 22;15(2):309. doi: 10.3390/v15020309.
  • Child abuse experience, training, knowledge, and attitude of healthcare professionals in sixty hospitals in Greece. Panagopoulou K, Gkentzi D, Fouzas S, Mentis M, Kostopoulou E, Plotas P, Papaevangelou V, Soldatou A, Karatza A, Bertzouanis A, Spyridakis I, Sfoungaris D, Zavras N, Salakos C, Blevrakis E, Sakellaris G, Kambouri K, Giapros V, Roupakias S, Jelastopulu E, Chantzi Z, Panagiotopoulos V, Varvarigou A, Dimitriou G, Sinopidis X. Eur Rev Med Pharmacol Sci. 2023 Jan;27(2):659-672. doi: 10.26355/eurrev_202301_31068. PMID: 36734738 Free article.
  • University faculty on student motivation to use medical education apps and barriers to their usage. Kagkelaris K, Mastronikolis S, Amasiadi N, Gerakaris A, Giorgalla V, Efthymiou P, Efstathiou I, Ziakas I, Katsifara A, Kitsos C, Kolios S, Konstantopoulou A, Kyprioti E, Papadopoulou MM, Razos N, Schinas I, Skourou K, Panayiotakopoulos G, Koniari I, Kounis NG, Georgakopoulos CD, Jelastopulu E, Plotas P. Eur Rev Med Pharmacol Sci. 2023 Feb;27(3):852-858. doi: 10.26355/eurrev_202302_31177.
  • Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2. Matsoukas JM, Gadanec LK, Zulli A, Apostolopoulos V, Kelaidonis K, Ligielli I, Moschovou K, Georgiou N, Plotas P, Chasapis CT, Moore G, Ridgway H, Mavromoustakos T. Biomedicines. 2022 Jul 18;10(7):1731. doi: 10.3390/biomedicines10071731.
  • Prevalence and Prognostic Factors of Stress Hyperglycemia in a Pediatric Population with Acute Illness in Greece-A Prospective Observational Study. Korakas E, Argyropoulos T, Koliou GA, Gikas A, Kountouri A, Nikolopoulou SK, Plotas P, Kontoangelos K, Ikonomidis I, Kadoglou NPE, Raptis A, Lambadiari V. J Clin Med. 2022 Feb 27;11(5):1301. doi: 10.3390/jcm11051301.
  • First Identified Case of Fatal Fulminant Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Necrotizing Hypersensitivity Reaction Different to Hypersensitivity or Drug-Induced Myocarditis. Kounis NG, Koniari I, Mplani V, Plotas P, Tsigkas G. J Clin Immunol. 2022 May;42(4):736-737. doi: 10.1007/s10875-022-01228-2. Epub 2022 Feb 17.
  • Fibroblast Growth Factor-2 (FGF-2) Expression in Pterygia Using Cell Spot Arrays. Mastronikolis S, Tsiambas E, Kagkelaris K, Pagkalou M, Plotas P, Mastronikoli S, Roukas D, Georgakopoulos CD. Vision (Basel). 2022 Sep 22;6(4):58. doi: 10.3390/vision6040058.
  • Anti-Diabetic Therapy, Heart Failure and Oxidative Stress: An Update. Koniari I, Velissaris D, Kounis NG, Koufou E, Artopoulou E, de Gregorio C, Mplani V, Paraskevas T, Tsigkas G, Hung MY, Plotas P, Lambadiari V, Ikonomidis I. J Clin Med. 2022 Aug 9;11(16):4660. doi: 10.3390/jcm11164660
  • The prognostic role of RBP-4 and adiponectin in patients with peripheral arterial disease undergoing lower limb endovascular revascularization.Kadoglou NPE, Korakas E, Karkos C, Maratou E, Kanonidis I, Plotas P, Papanas N, Moutsatsou P, Ikonomidis I, Lambadiari V. Cardiovasc Diabetol. 2021 Nov 10;20(1):221. doi: 10.1186/s12933-021-01411-6.
  • Anxiety and depression among parents of children with mild head injuries. Kallianezos P, Sinopidis X, Petropoulos C, Gkentzi D, Plotas P, Fouzas S, Karatza A, Jelastopulu E. Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1530-1535. doi: 10.26355/eurrev_202102_24861.
  • Possible protective role of contact Lens against SARS COV 2. Plotas P, Kagkelaris K, Konstantopoulou A, Makri O, Georgakopoulos CD. J Fr Ophtalmol. 2020 Jun 6:S0181-5512(20)30237-0. doi: 10.1016/j.jfo.2020.05.004.
  • Effects of electronic cigarette on platelet and vascular function after four months of use. Ikonomidis I, Katogiannis K, Kostelli G, Kourea K, Kyriakou E, Kypraiou A, Tsoumani M, Andreadou I, Lambadiari V, Plotas P, Thymis I, Tsantes AE. Food Chem Toxicol. 2020;141:111389. doi: 10.1016/j.fct.2020.111389.
  • Efficacy of Topical Ofloxacin 0.3 % Administration on Conjunctival Bacterial Flora in Diabetic Patients Undergoing Intravitreal Injections. Plotas P, Makri OE, Georgalas I, Pharmakakis N, Vantarakis A, Georgakopoulos CD. Semin Ophthalmol. 2017;32(6):738-42.
  • Knowledge, behaviours and attitudes regarding HPV infection and its prevention in female students in West Greece. Jelastopulu E, Fafliora E, Plota A, Babalis V, Bartsokas C, Poulas K, Plotas P*. Eur Rev Med Pharmacol Sci. 2016;20(12):2622-9
  • Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis. Deraos G, Rodi M, Kalbacher H, Chatzantoni K, Karagiannis F, Synodinos L, Plotas P, Papalois A, Dimisianos N, Papathanasopoulos P, Gatos D, Tselios T, Apostolopoulos V, Mouzaki A, Matsoukas J. Eur J Med Chem. 2015;101: 13-23